Baker McKenzie advised Basilea Pharmaceutica

Basilea Pharmaceutica completed a capital increase from authorized capital and set the placement price of CHF 45.75 per new share. A total of 1,000,000 new shares were sold in an accelerated bookbuilding to institutional investors. Accordingly, Basilea raised gross proceeds of CHF 45.75 million. Cantor Fitzgerald, Credit Suisse and Bryan Garnier acted as Joint Bookrunners in this PIPE transaction.

Basilea intends to use the net proceeds for i) the clinical development of Basilea’s clinical oncology drug candidates derazantinib and lisavanbulin, ii) pre-clinical research and development activities, and iii) working capital and other general corporate purposes, including investments in or in-licensing of complementary businesses, products or assets. The new shares will be admitted to trading on the International Reporting Standard segment of SIX Swiss Exchange as of February 26, 2021.

The team 

Baker McKenzie advised Basilea Pharmaceutica on all legal aspects of the this PIPE transaction. The team consisted of Matthias Courvoisier (Partner, Capital Markets – pictured left), Philip Spoerlé (Senior Associate, Capital Markets – pictured right), Yves Mauchle (Senior Associate, Capital Markets) and Jan Lusti (Junior Associate, Capital Markets) as well as U.S.-qualified capital markets partner Adam Farlow.

As previously reported by Legalcommunity.ch, Homburger advised the managers in connection with a private placement of newly issued shares in Basilea Pharmaceutica

Baker McKenzie advised Basilea Pharmaceutica

FabioAdmin

Legalcommunity.ch

Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio

SHARE

Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram